Susceptibility and trailing growth of Candida albicans to fluconazole: results of a Korean multicentre study

Mycoses. 2007 Mar;50(2):148-9. doi: 10.1111/j.1439-0507.2006.01329.x.

Abstract

The work reported here is the first nationwide, multicenter surveillance study conducted in Korea to obtain data on fluconazole susceptibility of Candida albicans (C. albicans) isolates. A total of 1137 isolates of C. albicans obtained from 17 university hospitals in South Korea during the 6-month period, July through December 2004, were tested. No resistant strains were observed in any of the isolates. Only five of the 1137 isolates (0.44%) of C. albicans were found to be susceptible dose dependent, with all remaining strains (99.56%) susceptible to fluconazole. Trailing growth at 48 h was found in only four isolates (0.35%).

Publication types

  • Letter
  • Multicenter Study

MeSH terms

  • Antifungal Agents / pharmacology*
  • Candida albicans / drug effects*
  • Candida albicans / growth & development*
  • Candida albicans / isolation & purification
  • Candidiasis / microbiology*
  • Drug Resistance, Fungal
  • Fluconazole / pharmacology*
  • Hospitals, University
  • Humans
  • Korea
  • Microbial Sensitivity Tests

Substances

  • Antifungal Agents
  • Fluconazole